【DT新材料】 获悉，2月2日， 道恩集团 在龙口市（道恩）新材料科技产业园举行签约仪式，正式并购韩国和承集团旗下的和承化学（越南）改性工 厂 。此举标志着道恩股份在俄罗斯、新加坡之后，其"市场国际化"版图新增越南坐标，深入切入东南亚市场。 此次并购的越南工厂位于越南同奈省仁泽县仁泽工业区，已建成投产5年，是当地重要的高分子新材料生产商。 该工厂主要生产PPS、PP、PE、ABS、 PA6/66等改性材料 ，产品广泛应用于电气电子、办公家具、汽车零部件等领域。 据悉，道恩近年来持续在海外考察合适标的，最终选择越南， 一方面，重要客户近年来在越南均有重要的制造基地，实现本地化就近供应，能够显著 降低跨境物流成本、缩短交付周期，提升供应链稳定性与响应速度，这是巩固战略合作的关键。 另一方面，越南市场本身充满活力，且当地还有一定 的优惠政策，这有利于道恩股份的产品辐射更广阔的东南亚市场，为公司长期国际化发展奠定坚实基础。 值得注意的是，此次收购并非简单的资产买卖，而是一套包含 "业务分立、股权转让、额外资产购买" 的复杂组合操作。 FINE 2026 × Carbontech 轻量化功能化与可持续材料展 2026. ...

2、公司 LCP 材料的整体进展情况如何？ 您好！随着 2025 年新增重庆 2 万吨 LCP 树脂项目一期、二期 产能的顺利投产，公司一方面持续深化在高频通讯、AI 算力服务 器、新能源汽车等领域的客户合作关系，另一方面加速推进 LCP 材料在手机主动散热、机器人电机等新兴应用场景的市场拓展。同 时，公司承接的中央预算内资金 LCP 薄膜项目已顺利通过验收， 未来将推动 LCP 薄膜在高端电子器件等领域的产业化进程，从而 显著提升产品附加值并强化技术壁垒。谢谢！ 3、公司除了 LCP 材料之外，其他新培育的几大特种材料推进 的怎么样？ 您好！2014 年，公司通过收购韩国三星 LCP 生产线，正式开 启特种高分子材料的战略转型。此后，公司坚持特种材料发展战略， 从 LCP 逐步扩展至特种尼龙、PTFE、PPS、PEEK、聚砜等多品类 特种材料领域，并已完成相应的产能布局。 证券代码：002886 证券简称：沃特股份 深圳市沃特新材料股份有限公司投资者关系活动记录表 编号：2026-01 | □ 投资者关系活动 | 特定对象调研 分析师会议 □ | | | --- | --- | --- | | □ | 媒体 ...

Investment Rating - The report maintains an "Overweight" rating for the petrochemical and basic chemical sectors [5] Core Insights - The bulk chemical industry is at a dual cycle inflection point, with profitability expected to recover as domestic and international demand improves in 2026 [1][3] - After a prolonged period of low profitability, the industry is entering a phase of reduced capacity expansion and inventory adjustments, with limited new capacity expected in 2026-2027 [2][3] - The dividend payout ratio for Chinese bulk chemical companies is anticipated to trend upwards due to decreased capital expenditure intensity compared to the 2015-2025 period [4] Summary by Sections Industry Overview - The bulk chemical industry has experienced a significant downturn in profitability since 2023, with a notable oversupply leading to continued low earnings through the second half of 2025 [2] - The industry is expected to enter a recovery phase in 2026 as demand begins to rebound [1][3] Capacity and Inventory Cycles - The current inventory cycle is at a turning point, with passive inventory replenishment observed since the second quarter of 2025, influenced by external demand factors [3] - The report indicates that the capacity expansion in the bulk chemical sector will be orderly during the "14th Five-Year Plan" period, with limited new capacity additions expected [2] Dividend and Capital Expenditure Trends - The report highlights that the capital expenditure intensity for the bulk chemical sector is likely to decrease significantly, leading to an increase in dividend payout ratios for companies in this space [4] - Recommended companies include Xinhengcheng, Wanhua Chemical, Hengli Petrochemical, and Sinopec A/H, which are expected to benefit from these trends [4][8]

| | | | --- | --- | | | | | . | 1 | | . | | | 市场数据: | 2026 年 01 月 12 日 | | --- | --- | | 收盘价（元） | 25.36 | | 一年内最高/最低（元） | 26.28/19.52 | | 市净率 | 2.4 | | 股息率%（分红/股价） | 3.55 | | 流通 A 股市值(百万元) | 77,015 | | 上证指数/深证成指 4,165.29/14,366.91 | | | 注："股息率"以最近一年已公布分红计算 | | | 基础数据: | 2025年09月30日 | | --- | --- | | 每股净资产 (元) | 10.48 | | 资产负债率% | 28.25 | | 总股本/流通 A 股 (百万) | 3,073/3,037 | | 流通 B 股/H 股 (百万) | -/- | 市公司 同研究人公司深 年内股价与大盘对比走势: 沪深300指数 相关研究 证券分析师 李绍程 A0230525070002 lisc@swsresearch.com 宋涛 A0230516070001 songtao@sw ...

Investment Rating - The report maintains an "Accumulate" rating for the company, indicating a positive outlook based on its growth potential and market position [6][7]. Core Insights - The company is positioned as a global leader in fine chemicals, focusing on domestic substitution and leveraging high-barrier core intermediates to drive growth across various segments, including nutritional products, flavors and fragrances, new materials, and pharmaceuticals [19][20]. - The nutritional products segment is expected to recover, with methionine prices anticipated to rise due to strong global demand and supply constraints [6][19]. - The company has a solid profit base and is poised for growth with the upcoming nylon integration project, which aims to address domestic production challenges in the industry [19][20]. Financial Data and Profit Forecast - Total revenue projections for 2025-2027 are estimated at 231.83 billion, 234.26 billion, and 244.78 billion yuan, respectively, with corresponding net profits of 67.33 billion, 72.02 billion, and 80.58 billion yuan [5][7]. - The company is expected to achieve a compound annual growth rate (CAGR) of 11% in net profit over the next three years, with earnings per share (EPS) projected at 2.19, 2.34, and 2.62 yuan for the same period [5][7]. - The company's price-to-earnings (PE) ratio for 2026 is estimated at approximately 11 times, which is below the average PE of comparable companies at 15 times, indicating potential undervaluation [7]. Market Position and Competitive Advantage - The company has established a strong market presence in the nutritional products sector, particularly in vitamins A and E, and is expanding its methionine production capacity to meet rising global demand [6][19]. - The flavors and fragrances segment is expected to grow steadily, supported by the company's leading position in the domestic market and ongoing product expansion efforts [6][19]. - In the new materials sector, the company is focusing on high-barrier processes and domestic substitution opportunities, with significant investments in projects like the nylon integration initiative in Tianjin [6][19]. Key Assumptions - The report assumes stable pricing for vitamins A and E, with a gradual recovery in methionine prices as production ramps up [8]. - The flavors and fragrances segment is expected to maintain steady growth, with a focus on expanding product offerings [8]. - The new materials segment is projected to benefit from the upcoming launch of the Tianjin nylon project, which is anticipated to contribute significantly to revenue starting in 2028 [8].

格隆汇1月9日丨新和成(002001.SZ)在投资者互动平台表示，公司PPS、PPA系列产品均有商业航天领域 订单。 ...

Core Viewpoint - Huatai Securities report indicates that New Hope Liuhe is a leading global enterprise in nutrition and flavoring, with sales of methionine, vitamins, and PPS ranking among the top five globally, showcasing integrated, scaled, and technological advantages [1] Group 1: Company Overview - New Hope Liuhe is positioned in emerging demands for human and animal nutrition, flavoring, and specialty engineering materials, establishing a solid technological foundation [1] - The company is entering a new growth cycle, driven by the increasing global market share of methionine and flavoring products, as well as breakthroughs in biomanufacturing and new materials [1] Group 2: Market Analysis - The market has overly focused on the cyclical fluctuations of vitamins, neglecting the growth potential of methionine and flavoring products, as well as the company's global competitive advantages and the investment value of emerging business growth [1] Group 3: Financial Projections - The profit forecast for 2025-2027 has been slightly adjusted upwards, reflecting the continued growth in methionine and flavoring products, with the target price raised to 38.24 yuan, representing a 49% increase, and the rating upgraded to "Buy" [1]

Group 1: Real Estate Industry - The core viewpoint is that the official launch of commercial real estate REITs marks a significant step towards a new development model in the real estate sector, with policies expected to accelerate the growth of C-REITs [2] - The introduction of 30 REITs-related policies by the CSRC and stock exchanges is seen as a catalyst for expanding asset classes and enhancing efficiency, which could lead to a revaluation of related assets and companies [2] - Companies deeply involved in commercial real estate and management services are expected to benefit significantly from this development [2] Group 2: Financial Services Industry - The recent guidelines from the central bank and financial regulatory authority aim to reduce the pricing cap for small loan companies, which may lead to a rapid industry cleanup [3] - The guidelines require small loan companies to stop issuing loans with comprehensive financing costs exceeding 24% immediately and to gradually lower pricing to within four times the one-year LPR by the end of 2027 [3] - The impact of these guidelines on the broader financial technology sector will depend on whether banks and consumer finance companies follow suit [3] Group 3: Transportation Industry - The outlook for January indicates a seasonal decline in passenger and cargo volumes, but there are positive signs for airline profitability and oil transportation demand [5] - The airline sector is expected to see improved revenue levels due to steady demand growth and favorable oil prices, while oil transportation rates may rise due to geopolitical tensions [5] - Recommendations include focusing on specific stocks in the airline and oil transportation sectors, as well as logistics and express delivery companies [5] Group 4: ETF Market - By the end of 2025, the total scale of ETFs in China surpassed 6 trillion yuan, with a significant increase driven by stock ETFs, which saw a 42% growth [5] - There is a notable divergence in the performance of broad-based ETFs and thematic industry ETFs, with the latter experiencing continued inflows [5] Group 5: Key Companies - Century Huatong is covered for the first time with a "buy" rating and a target price of 24.52 yuan, driven by its leadership in SLG games and strong performance in overseas markets [6] - New and emerging companies like Xinhecheng and Huaming Equipment are also highlighted for their growth potential and strategic initiatives, with target prices set at 38.24 yuan and 29.5 yuan respectively [10][12] - The report emphasizes the importance of product innovation and market expansion for companies like Sanqi Interactive Entertainment and China Jushi, which are expected to benefit from new game launches and incentive plans [8][9]

新和成（002001.SZ）12月28日在投资者互动平台表示，公司PPS四期项目已在稳步推进中，计划年产 能8000吨、2027年建成，生物基和常规产品均可以生产。 （文章来源：每日经济新闻） 每经AI快讯，有投资者在投资者互动平台提问：董秘，您好！贵公司PPS四期项目是否已启动建设？预 计什么时候可以建成投产？产能是多少？是生物基还是化学合成？ ...

每经AI快讯，有投资者在投资者互动平台提问：公司的那些产品可以在商业航天上获得应用？ 新和成（002001.SZ）12月20日在投资者互动平台表示，公司PPS、PPA产品可以在商业航天上应用。 （文章来源：每日经济新闻） ...